Contegra® 200H12 (UDI 00643169298644)Recalls & reported problems
Medtronic, Inc. · CNDT 200H12 CONTEGRA GBR1 HDE TEMP IND · Class f · Implant
All models of Contegra (35)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00643169298644), received between Apr 11, 2017 and Jan 11, 2023 — classified as 4 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Insufficient Device Problem Information4
- No Apparent Adverse Event1
Patient problems
- No Information2
- Aneurysm1
- No Known Impact Or Consequence To Patient1
- Pseudoaneurysm1
- Pulmonary Valve Insufficiency/ Regurgitation1
- Pulmonary Valve Stenosis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJan 11, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 6 YEARS AND 7 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A 1 YEAR 4 MONTH OLD PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A 18MM CONDUIT OF THE SAME MODEL. THE REASON FOR REPLACEMENT WAS REPORTED AS CONDUIT INSUFFICIENCY. IT WAS REPORTED THAT ANEURYSMAL DILATION AND THE APPEARANCE OF A PSEUDOANEURYSM WERE NOTED AT THE DISTAL END OF THE CONDUIT, WHICH WAS FOUND TO BE LIKELY SECONDARY TO OUTFLOW OBSTRUCTION DUE TO THE PATIENTS HISTORY OF HYPOPLASTIC PULMONARY ARTERIES. IT WAS ALSO REPORTED THAT A PROXIMAL LEFT AND RIGHT PULMONARY ARTERIOPLASTY WAS PERFORMED DURING THIS PROCEDURE. LASTLY, IT WAS REPORTED THAT POSTOPERATIVE BLEEDING WAS NOTED WHICH REQUIRED THREE ROUNDS OF PLATELETS, CRYOPRECIPITATE AND TWO DOSES OF NOVOSEVEN RECOMBINANT- FACTOR VII. A POST-REPAIR INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAM SHOWED NO SIGNIFICANT RIGHT VENTRICLE ( RV) TO PULMONARY ARTERY (PA) CONDUIT DYSFUNCTION OR STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Aneurysm; Pseudoaneurysm; Pulmonary Valve Insufficiency/ Regurgitation
MAUDE report 16137432 ↗InjuryOct 24, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR 4 MONTHS POST IMPLANT OF THIS PULMONARY VALVED CONDUIT IMPLANTED IN A 2 MONTH OLD PATIENT, A TRANSCATHETER BALLOON ANGIOPLASTY PROCEDURE WAS PERFORMED DUE TO DISTAL CONDUIT STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Pulmonary Valve Stenosis
MAUDE report 9234411 ↗InjuryOct 22, 2019No Apparent Adverse Event; Insufficient Device Problem Information; No Apparent Adverse Event; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 2 YEARS AND 10 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A (B)(6) PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN DEVICE. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; No Known Impact Or Consequence To Patient
MAUDE report 9221018 ↗InjuryApr 11, 2017Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT ONE YEAR, THREE MONTHS POST IMPLANT OF THIS BIOPROSTHETIC PULMONIC VALVED CONDUIT IN A PEDIATRIC PATIENT, THIS DEVICE WAS EXPLANTED AND REPLACED. NO FAILURE MECHANISM AND NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 6483124 ↗
Other pulmonic valved conduit devices
- Contegra® 200H12Medtronic, Inc. · pulmonic valved conduit1 death29 reports
- Contegra® 200H14Medtronic, Inc. · pulmonic valved conduit2 deaths24 reports
- Contegra® 200H16Medtronic, Inc. · pulmonic valved conduit18 reports
- Contegra® 200H18Medtronic, Inc. · pulmonic valved conduit16 reports
- Contegra® 200SH22Medtronic, Inc. · pulmonic valved conduit12 reports
- Contegra® 200H18Medtronic, Inc. · pulmonic valved conduit12 reports
- Contegra® 200H12Medtronic, Inc. · pulmonic valved conduit11 reports
- Contegra® 200H20Medtronic, Inc. · pulmonic valved conduit11 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page